Cardiovascular risk reduction in older people with type 2 diabetes mellitus-a comprehensive narrative review
PEH Si, S Parker, D Abdelhafiz, A Summerbell… - Diabetes Research and …, 2024 - Elsevier
Metabolic targets are controversial in older people with type 2 diabetes due to functional
heterogeneity and morbidity burden. Tight blood pressure and metabolic control appears …
heterogeneity and morbidity burden. Tight blood pressure and metabolic control appears …
Efficacy and safety of a four-drug, quarter-dose treatment for hypertension: the QUARTET USA randomized trial
MD Huffman, AS Baldridge, D Lazar, H Abbas… - Hypertension …, 2024 - nature.com
New approaches are needed to lower blood pressure (BP) given persistently low control
rates. QUARTET USA sought to evaluate the effect of four-drug, quarter-dose BP lowering …
rates. QUARTET USA sought to evaluate the effect of four-drug, quarter-dose BP lowering …
Race, ethnicity, and considerations for data collection and analysis in research studies
S Sharghi, S Khalatbari, A Laird, J Lapidus… - Journal of Clinical and …, 2024 - cambridge.org
Research studies involving human subjects require collection of and reporting on
demographic data related to race and ethnicity. However, existing practices lack …
demographic data related to race and ethnicity. However, existing practices lack …
Examining the impact of the QUARTET USA trial using the translational science benefits model
G Iyer, D Lazar, AS Baldridge, J Mejia… - Journal of Clinical and …, 2024 - cambridge.org
Evaluation of benefits beyond quantitative academic outputs is essential in determining
translational research value. We used the Translational Science Benefits Model (TSBM) to …
translational research value. We used the Translational Science Benefits Model (TSBM) to …